Ann D. Rhoads, Director at Repare Therapeutics Inc. (RPTX), bought 4,000 shares at $20.00 ($80K) on 2020-06-23, disclosed to the SEC on 2020-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GMED | SELL | 2025-09-16 | $585K | — | Filing → |
| GMED | SELL | 2025-03-04 | $590K | — | Filing → |
| GMED | SELL | 2024-09-17 | $1.1M | — | Filing → |